LibraryBy pinki shah / May 14, 2022 Speciality — Amyotrophic Lateral Sclerosis (ALS) Biomarkers Biosimilars Bladder Blood Bone Brain Breast Cancer Central Nervous System (CNS) Clinical Trials Colon Colorectal Diversity, Equity & Inclusion Featured Content Gastrointestinal Genitourinary Genomic Geriatric Gynecology Head and Neck Hematologic Hematologic Maglinencies Hematology Immunotherapy Interventional Radiology Kidney Leukemia Liquid Biopsy Liver Lung Lymphoma Malignencies Melanoma Myelodysplastic Syndrome Myeloma Neuroendocrine Novel Oral & Maxillofacial Surgery Ovarian Pancreas Pancreatic Pharmacological Prostate Radiation Radiology Renal Sarcoma Skin Solid Tumor Supportive & Palliative Care Survivorship Telemedicine Thoracic Thrombosis Thymic Thyroid Urothelial Author / Speaker Title of Presentation Type of Media — Video Document Audio Event 2024 Event — 2024 California Cancer Consortium Conference (CCC) 2024 MLS Cleveland 2024 MLS Nashville 2024 MLS New Orleans 2024 MLS Seattle 2024 New Orleans Summer Cancer Meeting (NOSCM) 2024 PRIMO 2024 SPS Puerto Rico 2024 SPS Seattle 2024 SPECTRUM 2024 Sylvester APP Oncology Symposium 2024 WCS Clear Displaying 1,851 - 1,875 of 2,573 « 1 … 73 74 75 76 77 … 103 » Later lines of Treatment for NSCLC By: Tejas Patil, MD View PDF Later lines of Treatment for NSCLC By: Tejas Patil, MD View Video Tumor Biology, Pathology, Novel Diagnostics By: Tianhong “Tina” Li, MD, PhD View PDF Tumor Biology, Pathology, Novel Diagnostics By: Tianhong “Tina” Li, MD, PhD View Video Tumor Biology, Pathology, Novel Diagnostics By: Tianhong “Tina” Li, MD, PhD View Video Tumor Biology, Pathology, Novel Diagnostics By: Tianhong “Tina” Li, MD, PhD View PDF Tumor Biology, Pathology, Novel Diagnostics By: Tianhong “Tina” Li, MD, PhD View PDF Tumor Biology, Pathology, Novel Diagnostics By: Tianhong “Tina” Li, MD, PhD View Video What After Immunotherapy Failure in First Line: Is There Hope? By: Ticiana A. Leal, MD View PDF What After Immunotherapy Failure in First Line: Is There Hope? By: Ticiana A. Leal, MD View Video Immunotherapy in Metastatic NSCLC: How to Choose Initial Therapy and What’s New? By: Tina Cascone, MD, PhD View PDF Other Driver Mutations in Lung Cancer - RET,ERBB2, MET, NTRK By: Tom Stinchcombe View PDF Targeted Therapy in Lung Cancer By: Vamsi Velcheti, MD View PDF How to Rescue Patients from Osimertinib Resistance By: Wade T. Iams, MD, MSCI View PDF How to Rescue Patients from Osimertinib Resistance By: Wade T. Iams, MD, MSCI View Video K-RAS and ERBB2 Mutation in NSCLC By: Yasir Elamin, MD View PDF K-RAS and ERBB2 Mutation in NSCLC By: Yasir Elamin, MD View Video Lung Cancer Immunotheraphy Case Presentation By: Yasmin Hajja, MD View PDF Lung Cancer Immunotheraphy Case Presentation By: Yasmin Hajja, MD View Video Lymphoma: State of the Art By: Alex Herrera, MD View PDF Lymphoma: State of the Art By: Alex Herrera, MD View Video Waldenstrom’s Macroglobulinemia By: Andrew Branagan, MD, PhD View PDF Waldenstrom’s Macroglobulinemia By: Andrew Branagan, MD, PhD View Video Case Presentation: NHL By: Arnaldo Rojas Figueroa, MD View PDF New Strategies for MCL By: Bijal Shah, MD, MS View PDF
